Acute migraine headaches occur often, usually one to four times a month..

AZ-104 and AZ-004 generic singulair are being developed through Symphony Allegro, a product development partnership formed between Alexza and Symphony Capital, LLC. "We previously announced initial results with AZ-104 in an in-clinic setting, showing its positive effect fucicort antibiotic cream can affect the patient with stent treating pain and other key symptoms of migraine headache," said pain relief Kendricks B. AZ-104 is a lower-dose version of AZ-004 (Staccato loxapine), Alexza's lead product candidate that is in late Phase 3 clinical development synthroid hair loss lot generic estrace for the acute treatment of agitation in patients with schizophrenia or bipolar disorder. The primary efficacy endpoint for the trial is headache pain relief at 2 hours urinary tract pain relief medication post-dose, using the standard 4-point rating verapamil scale (International Headache Society). ALXA) announced today that it has initiated a Phase 2b clinical trial with AZ-104 (Staccato loxapine) in patients with migraine headaches.

"We believe the potential value of antibiotics the non-invasive nature and rapid onset of pharmacological celexa action provided by our Staccato system is well-suited for migraine pain relief in the outpatient setting. The Company has previously announced positive results in two Phase 3 trials of AZ-004 and expects to submit a New Drug Application for AZ-004 in bevon 2010. King, Alexza President and CEO. Data from this outpatient clinical trial will guide our future development plans for AZ-104 for the treatment of migraine headaches." About Acute Migraine Headaches online pharmacist According to the National Headache Foundation, approximately 13 million people in the United States have been diagnosed with migraine headaches.

Secondary citalopram and dietpills generic imitrex efficacy endpoints for the trial include pain relief and other symptom assessments at various time points. The AZ-104 Phase 2b clinical trial is an augmentin outpatient, multi-center, randomized, double-blind, single-dose, placebo-controlled study in approximately 360 patients who have migraines, with or without aura. seasonale birth control price Alexza Initiates AZ-104 (Staccato(R) Loxapine) Phase 2b Clinical Trial in Patients With Migraine Headaches MOUNTAIN VIEW, Calif., / - / -- Alexza Pharmaceuticals, Inc. Three doses will be evaluated in the clinical trial, placebo and two doses of AZ-104 (1.25 and 2.5 mg).

Safety evaluations will also be made throughout the clinical trial period.